Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (FRA:FDY)
Germany flag Germany · Delayed Price · Currency is EUR
0.3240
+0.0060 (1.89%)
At close: Jan 9, 2026

FRA:FDY Statistics

Total Valuation

FRA:FDY has a market cap or net worth of EUR 884.71 million. The enterprise value is 751.86 million.

Market Cap884.71M
Enterprise Value 751.86M

Important Dates

The next estimated earnings date is Tuesday, March 31, 2026.

Earnings Date Mar 31, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 326.00M
Shares Outstanding n/a
Shares Change (YoY) -24.84%
Shares Change (QoQ) -69.39%
Owned by Insiders (%) 21.00%
Owned by Institutions (%) 2.91%
Float 451.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 10.38
PB Ratio 3.27
P/TBV Ratio 3.37
P/FCF Ratio 74.42
P/OCF Ratio 49.39
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -100.21
EV / Sales 8.77
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 63.25

Financial Position

The company has a current ratio of 8.68, with a Debt / Equity ratio of 0.01.

Current Ratio 8.68
Quick Ratio 8.40
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF 0.16
Interest Coverage -152.80

Financial Efficiency

Return on equity (ROE) is -2.73% and return on invested capital (ROIC) is -2.83%.

Return on Equity (ROE) -2.73%
Return on Assets (ROA) -2.58%
Return on Invested Capital (ROIC) -2.83%
Return on Capital Employed (ROCE) -4.59%
Revenue Per Employee 92,303
Profits Per Employee -8,129
Employee Count925
Asset Turnover 0.28
Inventory Turnover 1.88

Taxes

Income Tax -3.80M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 171

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FRA:FDY had revenue of EUR 85.20 million and -7.50 million in losses. Loss per share was -0.01.

Revenue85.20M
Gross Profit 76.40M
Operating Income -12.58M
Pretax Income -11.33M
Net Income -7.50M
EBITDA -6.03M
EBIT -12.58M
Loss Per Share -0.01
Full Income Statement

Balance Sheet

The company has 133.92 million in cash and 1.91 million in debt, with a net cash position of 132.01 million.

Cash & Cash Equivalents 133.92M
Total Debt 1.91M
Net Cash 132.01M
Net Cash Per Share n/a
Equity (Book Value) 270.42M
Book Value Per Share 0.26
Working Capital 162.66M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.91 million and capital expenditures -6.03 million, giving a free cash flow of 11.89 million.

Operating Cash Flow 17.91M
Capital Expenditures -6.03M
Free Cash Flow 11.89M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 89.68%, with operating and profit margins of -14.76% and -8.81%.

Gross Margin 89.68%
Operating Margin -14.76%
Pretax Margin -13.30%
Profit Margin -8.81%
EBITDA Margin -7.08%
EBIT Margin -14.76%
FCF Margin 13.95%

Dividends & Yields

FRA:FDY does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 24.84%
Shareholder Yield 24.84%
Earnings Yield -0.85%
FCF Yield 1.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FRA:FDY has an Altman Z-Score of 21.65 and a Piotroski F-Score of 4.

Altman Z-Score 21.65
Piotroski F-Score 4